| ￥1200 | |
| A03296-50 | |
|
|
|
|
|
|
|
|
|
| Specificity | This product is specific to 14-3-3 alpha/beta |
| Host Species | Rabbit |
| Immunogen | A synthesized peptide derived from human 14-3-3 alpha/beta |
| Species Reactivity | Human; Mouse; Rat |
| Conjugate | Unconjugated |
| Working concentrations for specific applications should be determined by the investigators. The appropriate concentrations may be affected by secondary antibody affinity, antigen concentration, the sensitivity of the method of detection, temperature, the length of the incubations, and other factors. The suitability of this antibody for applications other than those listed below has not been determined. The following concentration ranges are recommended starting points for this product. | |||||||||||||||
|
|||||||||||||||
| Form | Liquid |
| Storage Buffer | Supplied in 10mM phosphate buffered saline , pH 7.4, 150mM sodium chloride, 0.05% BSA, 0.02% sodium azide and 50% glycerol. |
| Storage Instructions | Store at -20°C. This product is stable for 1 year upon receipt, when handled and stored as instructed. |
| Purification | Affinity-chromatography |
| Isotype | Rabbit IgG |
| Clonality | Monoclonal |
Western blot analysis of 14-3-3 alpha + beta expression in Hela lysate. »
| Target Background | Adapter protein implicated in the regulation of a large spectrum of both general and specialized signaling pathways. Binds to a large number of partners, usually by recognition of a phosphoserine or phosphothreonine motif. Binding generally results in the modulation of the activity of the binding partner. Negative regulator of osteogenesis. |
| Synonyms | 14 3 3 protein beta/alpha; Brain protein 14 3 3 beta isoform; GW128; HS 1; KCIP-1; KCIP1; Protein 1054; Protein kinase C inhibitor protein 1; YWHAA; YWHAB; |
For research use only. Not intended for human or animal clinical trials, therapeutic or diagnostic use.
